The US Biosimilars Patent Litigation Outlook For 2019
In 2010, President Barack Obama signed the Biologics Price Competition and Innovation Act into law as part of the Affordable Care Act, establishing an abbreviated regulatory pathway for biosimilar approvals and...To view the full article, register now.
Already a subscriber? Click here to view full article